A Single-center, Randomized, Open-label, Single-dose Study of Polysaccharide Superparamagnetic Iron Oxide Injection in Healthy Subjects to Evaluate Magnetic Resonance Imaging in Multiple Dose Groups
Latest Information Update: 01 Sep 2023
At a glance
- Drugs Domestic polysaccharide superparamagnetic iron oxide nanoparticle-Chia Tai Tianqing Pharmaceutical Group (Primary)
- Indications Coronary disorders
- Focus Adverse reactions
- Sponsors Chia Tai Tianqing Pharmaceutical Group
Most Recent Events
- 01 Sep 2023 New trial record